Cannabis Law Report

MAY 1, 2022

A new report by New Frontier Data estimated that U.S. legal and illicit cannabis consumer spending reached an estimated US$97 billion in 2021, according to a new report by New Frontier Data. Cannabis is no longer a one-size-fits-all industry,” Gary Allen, CEO of New Frontier Data, said in a statement.

Data 52

Data Legalization Consumption Collective 52

Veriheal

FEBRUARY 21, 2023

Despite notable advances in MMJ research over the last decade, scientists have found that some states’ restrictions on qualifying conditions prevent millions of patients from getting the treatments they need—robbing them of potential relief offered by cannabinoid therapies. Many patients take MMJ for more reasons than one.

Access 98

Access Patients Chronic Pain Conditions 98

SpeedWeed

MAY 1, 2021

The new Cultivar Collection from Trulieve demonstrates how a multi-state player can stay craft at its core. Crafting the Cultivar Collection. The proof is in the pudding with Trulieve’s new Cultivar Collection. Grape Cake from the Cultivar Collection. The Cultivar Collection was no overnight feat.

Collective 52

Collective Trichome Terpenes Strains 52

Cannabis Law Report

AUGUST 20, 2022

CHICAGO — Governor JB Pritzker and the Illinois Department of Financial and Professional Regulation (IDFPR) today issued three additional Conditional Adult Use Dispensing Organization Licenses to applicants selected in lotteries held in the summer of 2021. Secretary of the Illinois Department of Financial and Professional Regulation.

Conditions 52

Conditions Dispensary Programs Business 52

Cannabis Law Report

AUGUST 14, 2019

Let’s take a closer look at five key ways big data and technology are directly impacting the industry. Big Data Streamlines the Marijuana Regulatory Process and Helps Close the Scientific Research Gap. Therefore, the growing marijuana market lacks the clinical data needed to help marijuana businesses create new and better products.

Data 45

Data Research and Development Marijuana Collective 45

Cannabis Law Report

NOVEMBER 14, 2019

million adults are now using “street cannabis ” to treat the symptoms of chronic conditions , according to the largest poll of its kind. More than half (56 per cent) of those using cannabis for their conditions did so on a daily basis, with a further 23 per cent on a weekly basis. They write. New guidelines.

Conditions 45

Conditions Data Medicine Collective 45

Veriheal

FEBRUARY 9, 2023

The data collected so far by the Turner Institute for Brain and Mental Health at Monash University in Australia suggests that psilocybin not only makes the process more comfortable but, as one participant described, MRIs become “magical.”

Clinical Trials 98

Clinical Trials Research and Development Data Collective 98

Veriheal

JUNE 27, 2023

After over four years of observation, the researchers found no traces of Chronic Obstructive Pulmonary Disease (COPD) —a condition commonly associated with tobacco smoking, characterized by coughing and shortness of breath—whether in developmental or advanced stages.

Research and Development 104

Research and Development Data Collective Vaping 104

Cannabis Law Report

AUGUST 2, 2021

The nearly 3,000 participant study will capture and publish the most comprehensive data ever collected on CBD product effectiveness from 13 commercially available U.S. Radicle ACES is Institutional Review Board (IRB) approved and will capture CBD effectiveness data directly from nearly 3,000 study participants.

CBD 105

CBD Data Sleep Clinical Trials 105

Cannabis Law Report

AUGUST 3, 2021

(CSE: MXT) (OTCQB: MXTTF) aims to address these problems by pairing biometric interviews with brainwave data to create a proprietary mental health reference database. Using machine learning algorithms and qualified practitioner input, the company is leveraging that data to build tools that deliver digital diagnostic opinions.

Research and Development 105

Research and Development Data Conditions Therapy 105

Cannabis Law Report

JUNE 1, 2021

Given the size and scale of the study, RYAH has developed a custom software solution, using OAuth API-integration to protect the privacy of the participants in the study, with the goal of enabling a fully integrated, patient feedback and data collection capability. About RYAH Group, Inc. RYAH Group, Inc.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Cannabis Law Report

DECEMBER 2, 2021

The results of the clinical trial have been submitted in the Clinical/Statistical Report (“CSR”) filed with the FDA, and relevant data is also available on Form 8-K filed with the SEC on December 2, 2021. Alzheimer’s disease impacts about 50 million people worldwide and about 5.5 million individuals in the U.S.

Clinical Trials 52

Clinical Trials Data Patients THC 52

Cannabis Law Report

DECEMBER 14, 2021

(“IGC” or the “Company”) today announced positive primary endpoint data for its Phase 1 clinical trial for IGC-AD1, which is a proprietary cannabinoid-based investigational new drug candidate for patients who have Alzheimer’s disease. Food and Drug Administration (FDA) on December 1, 2021.

Clinical Trials 52

Clinical Trials Safety Data Patients 52

Cannabis Law Report

JUNE 23, 2021

Medicann is launching an observational study using RYAH Smart Dry Herb Inhalers in order to collect patient feedback on consumption of cannabis strains available on the Island, including strains supplied by Aurora Europe , a subsidiary of Canadian-headquartered Aurora Cannabis Inc., About RYAH Group, Inc. RYAH Group, Inc.

Programs 100

Programs Data Events Collective 100

MedicalJane

JUNE 12, 2020

All of the participants self-reported that they or their dependent patient had a diagnosed health condition at the time of the baseline assessment. The control group consisted of 271 adult patients who were considering cannabis use, and 197 adult caregivers who were considering it for a dependent child or adult patient.

Chronic Pain 145

Chronic Pain Epilepsy Patients Medicine 145

Cannabis Law Report

DECEMBER 8, 2021

Global Psychiatry Partnering 2014 to 2021 provides the full collection of Psychiatry disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Access to headline, upfront, milestone and royalty data. Under what conditions can the deal be terminated? How are disputes to be resolved?

Access 52

Access Data Pharmaceutical Research and Development 52

Project CBD

MARCH 21, 2023

She was upset with herself for being so careless and concerned that the condition would persist. For many other people of all ages, tinnitus is indeed a chronic condition that has nothing to do with loud ‘80s cover bands in small clubs. While the collective evidence to date is mixed and inconclusive, it’s also incomplete.

Cannabinoids 144

Cannabinoids Clinical Trials Sleep Blood Pressure 144

Cannabis Law Report

AUGUST 10, 2021

The Hawthorne Collective to Invest $150 million in Canadian-based RIV Capital. To that end, The Hawthorne Collective will provide a $150 million convertible loan to Toronto-based RIV Capital (TSX: RIV) (OTC: CNPOF), a cannabis investment and acquisition firm currently listed on the Toronto Stock Exchange. MARYSVILLE, Ohio, Aug.

Collective 105

Collective Hydroponic Events Business 105

Veriheal

AUGUST 23, 2023

Over the span of a month, the participants were closely monitored, providing a total of 192 observations to form a robust data set. To capture the real-world impacts of microdosing psilocybin, the researchers collected self-assessments that applied an ‘experience sampling’ method using a phone application.

Microdosing 98

Microdosing Data Treatment Conditions 98

United Patients Group

JUNE 8, 2023

It replaces traditional paper-based forms and manual data entry, improving efficiency, accuracy, and patient experience. Data Capture: This tool can capture patient information like demographic details, contact information, insurance details, medical history, allergies, and medication information.

Patients 52

Patients Data Collective Environment 52

Cannabis Law Report

OCTOBER 26, 2021

Last week, the National Agricultural Statistics Service (NASS) began collecting data for its first ever Hemp Acreage and Production Survey. Yet, there is no comprehensive, national production data for it. NASS is the federal statistical agency responsible for producing official data about U.S. on a dry weight basis.

Hemp 52

Hemp Agriculture Data Collective 52

Cannabis Law Report

JULY 19, 2021

The data from the study is expected to be embedded into the RYAH MD platform, with the goal of enabling healthcare professionals to administer THC, CBD and terpenes in milliliters, which are then expected to automatically be converted into milligrams to allow for a customized, targeted patient inhalation session. “Our billion by 2027.

Therapy 76

Therapy Data Research and Development Events 76

FloridaMarijuana.net

JUNE 27, 2018

The study’s data showed that “Cannabis significantly reduced ratings of depression, anxiety, and stress.” Participants in the study recorded their personal experience when using cannabis for their depression and other mental conditions such as anxiety and stress; scientists were able to use data collected from the app to analyze the results.

Treatment 100

Treatment Marijuana Conditions Data 100

Veriheal

JANUARY 16, 2024

By focusing on this specific demographic, the team aimed to not only collect raw data but also gain insights into the motivations and experiences that led these caregivers to explore CBD as a therapeutic option for their children. Always consult a physician before making any decision on the treatment of a medical condition.

Patients 113

Patients CBD Treatment Research and Development 113

Cannabis Law Report

JUNE 30, 2021

Yet, despite nearly two billion people with mental illness each year, these conditions are routinely misdiagnosed and inadequately treated. In addition, the company aims to predict what treatments are most effective in addressing these conditions, including psychedelics, which have shown tremendous promise in early clinical trials.

Treatment 52

Treatment Clinical Trials Research and Development Data 52

Cannabis Law Report

DECEMBER 11, 2021

This reduction in prices will make the clinic the cheapest option for many patients looking to receive medical cannabis treatments for a wide variety of conditions and illnesses. Medical cannabis can be considered as a treatment for a number of conditions – including chronic pain, epilepsy, and insomnia – when first-line options have failed.

Access 52

Access Patients Chronic Pain Treatment 52

CannaMD

JULY 23, 2020

In the novel study conducted by researchers at the University of New Mexico, nearly 2,000 people self-administered cannabis over a three-year period and reported their marijuana use via the Releaf App that was specifically designed for the study’s data collection needs. Human reports to date on the subject are largely anecdotal.

Data 90

Data Chronic Pain Sleep Patients 90

Cannabis Law Report

MARCH 22, 2020

A data firm is warning those infected with the novel coronoavirus to avoid consuming products that contain tetrahydrocannabinol (THC), the main psychoactive component of cannabis. Data CEO Julie Armstrong said her company knows the COVID-19 affects the population in a similar way to influenza. The brief survey can be taken here.

THC 59

THC Clinical Trials Data Consumption 59

Cannabis Law Report

JULY 11, 2022

Any cultivation tax collected on cannabis that enters the commercial market on or after July 1, 2022, must be returned to the cultivator that initially paid the cultivation tax or, if unable to be returned to the cultivator, must be paid to CDTFA as excess tax. Delivery Data Required to be Reported in Metrc.

Cultivation 52

Cultivation Law Collective Retail 52

Cannabis Law Report

APRIL 1, 2022

The General Council of Pharmacists has proposed this Monday to carry out a pilot test in pharmacies to assess the use of cannabis for therapeutic purposes, a product that, in the opinion of the president of pharmacists, could have a similar use and conditions of use to those that have other compounds such as morphine.

Medicine 52

Medicine Data Safety Conditions 52

Cannabis Law Report

JUNE 19, 2022

Partnership will focus on the collection and analysis of digital biomarkers to identify signs of response and relapse in upcoming Phase 2 clinical trials. Beckley Psytech aims to track and improve patient experience through an integrated, digitally-assisted treatment model. June 14, 2022 02:00 AM Eastern Daylight Time.

Clinical Trials 52

Clinical Trials Patients Research and Development Treatment 52

The Cannigma

OCTOBER 22, 2023

The Cannigma has always taken a data-informed approach to content creation – though up until recently we’ve been primarily leaning on the existing peer-reviewed literature to guide our content. We need more data – human data – on specific applications for the plant – symptoms, use cases, conditions and patient types.

Data 88

Data Research and Development Sleep Collective 88

Veriheal

MAY 17, 2023

Michelle Lujan Grisham assented to 211 bills, vetoing 13, including Senate Bill 84 and Senate Bill 187 , which collectively lobbied against incarceration for minor drug-related offenses and technical violations. On April 7, New Mexico Gov. The executive veto has received strong criticism from many individuals and organizations.

Treatment 98

Treatment Policy Legislation Collective 98

Veriheal

DECEMBER 23, 2022

Dr. Maxwell’s team also collected data contained in samples sourced from California. After a close analysis of the data, the team determined that an absence of consistent federal guidelines regarding marijuana contaminants ultimately increases the risk of consumers developing health issues.

Research and Development 93

Research and Development Agriculture Data Extraction 93

Veriheal

MAY 30, 2022

Our most recent data shows how cannabinoids via industrial hemp decreased the stress hormone cortisol as well as the inflammatory biomarker prostaglandin E2. He adds, “The initial data we have collected is essential should industrial hemp and its by-product be considered by the U.S. milligrams CBDA daily.

Hemp 104

Hemp Cannabinoids Concentrates Agriculture 104

Canna Law Blog

JANUARY 17, 2023

A licensee automatically receives conditional approval after five days if a determination is still pending. Note: that link concerns the draft rule before the OLCC added the conditional approval “after five days” language to the proposed rule; but several other issues we identified remain in the rule as adopted).

Retail 71

Retail Cannabis Conditions Business 71

The Joint Blog

DECEMBER 20, 2020

“Respondents reported a median score of 90 on a zero to 100-point scale in response to the question, “How does cannabis affect your conditions or symptoms overall?” Materials and Methods: A cross-sectional online survey of those using cannabis for health-related conditions run between May and July 2019.

Sleep 49

Sleep Data Pharmaceutical Marijuana 49